Home / Companies / Procyrion

Texas Health Atlas · Houston

Procyrion

Developing Aortix, a percutaneous mechanical circulatory support device for heart failure patients with cardiorenal syndrome.

Location
Houston, Texas
Focus
MedTech
Stage / status
Investigational (pivotal IDE trial)
Notes
Aortix is investigational and being studied in the DRAIN-HF pivotal IDE trial; it is not available for sale in any country.
Website
procyrion.com
Last reviewed
Sep 29, 2026

Coverage

Future Health ExplainedCleared, approved, De Novo, Breakthrough: how FDA medical device pathways workWhat "FDA-cleared", "FDA-approved", De Novo, IDE and Breakthrough designation actually mean, with examples from Texas medtech companies.Sep 29, 2026

Sources

  1. www.procyrion.com/
  2. www.procyrion.com/clinical-trials

Regulatory status is as stated by the company or its public filings on the review date; it changes. Work here? Send a correction or update.